GSK fundamentals
GSK PLC ORD GBP0.3125 revenue breakdown overview
GSK PLC ORD GBP0.3125 revenue for the last year amounted to 31.38 B GBP, the most of which — 31.38 B GBP — came from its highest performing source at the moment, Commercial Operations, the year earlier bringing 30.33 B GBP. The greatest contribution to the revenue figure was made by United States — last year it brought GSK PLC ORD GBP0.3125 16.38 B GBP, and the year before that — 15.82 B GBP.
By source
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
0.00
9.00 B
18.00 B
27.00 B
36.00 B
Commercial Operations
Pharmaceuticals
Consumer Healthcare
Vaccines
Corporate and Other Unallocated
Global Pharmaceuticals
Human Immunodeficiency Virus
Pharmaceuticals and Vaccines
Currency: GBP
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Commercial Operations
—
—
29.32 B
30.33 B
31.38 B
Pharmaceuticals
17.06 B
17.73 B
—
—
—
Consumer Healthcare
10.03 B
9.61 B
—
—
—
Vaccines
6.98 B
6.78 B
—
—
—
Corporate and Other Unallocated
28.00 M
—
—
—
—
Global Pharmaceuticals
—
—
—
—
—
Human Immunodeficiency Virus
—
—
—
—
—
Pharmaceuticals and Vaccines
—
—
—
—
—
By country
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
0.00
9.00 B
18.00 B
27.00 B
36.00 B
United States
Rest of World
United Kingdom
Europe
Currency: GBP
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
United States
14.56 B
15.09 B
14.54 B
15.82 B
16.38 B
Rest of World
11.38 B
11.18 B
14.09 B
13.81 B
14.28 B
United Kingdom
980.00 M
975.00 M
695.00 M
693.00 M
708.00 M
Europe
7.18 B
6.86 B
—
—
—